1. Synthesis and Evaluation of 3-Substituted-4-(quinoxalin-6-yl) Pyrazoles as TGF-β Type I Receptor Kinase Inhibitors
   Li-Min Zhao et al, 2018, Molecules CrossRef
2. Paeonol alleviates CCl4-induced liver fibrosis through suppression of hepatic stellate cells activation via inhibiting the TGF-β/Smad3 signaling
   Shengwang Wu et al, 2019, Immunopharmacology and Immunotoxicology CrossRef
3. Synthesis and evaluation of the HIF-1α inhibitory activity of 3(5)-substituted-4-(quinolin-4-yl)- and 4-(2-phenylpyridin-4-yl)pyrazoles as inhibitors of ALK5
   Yan-Wei Li et al, 2019, Bioorganic & Medicinal Chemistry Letters CrossRef
4. Administration of a mixture of triterpenoids from yeyachun and phenolic acids from danshen ameliorates carbon tetrachloride-induced liver fibrosis in mice by the regulation of intestinal flora
   Yang Tan et al, 2020, Journal of Pharmacological Sciences CrossRef
5. Komagataeibacter hansenii CGMCC 3917 alleviates alcohol-induced liver injury by regulating fatty acid metabolism and intestinal microbiota diversity in mice
   Dehui Lin et al, 2020, Food Funct. CrossRef
6. Effect of intestinal microbiota imbalance associated with chronic hepatitis B virus infection on the expression of microRNA‑192 and GLP‑1
   Yinghui Liu, 2021, Mol Med Rep CrossRef
7. Theory of the exterior–interior relationship between the lungs and the large intestine to explore the mechanism of Eriobotrya japonica leaf water extract in the treatment of cough variant asthma
   Qian He et al, 2021, Journal of Ethnopharmacology CrossRef
8. Chitosan based encapsulation increased the apoptotic efficacy of thymol on A549 cells and exhibited non toxic response in swiss albino mice
   Devasahayam Jaya Balan et al, 2022, International Journal of Biological Macromolecules CrossRef
9. Aspirin attenuates liver fibrosis by suppressing TGF‑β1/Smad signaling
   Yimin Sun et al, 2022, Mol Med Rep CrossRef
10. The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis
    Yu-Lin Zhang et al, 2022, Front. Cell. Infect. Microbiol. CrossRef
11. Aronia melanocarpa polysaccharide ameliorates liver fibrosis through TGF-β1-mediated the activation of PI3K/AKT pathway and modulating gut microbiota
    Yingchun Zhao et al, 2022, Journal of Pharmacological Sciences CrossRef
12. Compound Probiotic Ameliorates Acute Alcoholic Liver Disease in Mice by Modulating Gut Microbiota and Maintaining Intestinal Barrier
    Haixia Liu et al, 2022, Probiotics & Antimicro. Prot. CrossRef
13. The gut microbiota: A new perspective for tertiary prevention of hepatobiliary and gallbladder diseases
    Xiaoyu Huang et al, 2023, Front. Nutr. CrossRef
14. Tiaogan Jiejiu Tongluo Formula attenuated alcohol-induced chronic liver injury by regulating lipid metabolism in rats
    Chunqiu Fang et al, 2023, Journal of Ethnopharmacology CrossRef
15. Polyethylene microplastics induced gut microbiota dysbiosis leading to liver injury via the TLR2/NF-κB/NLRP3 pathway in mice
    Ran Xu et al, 2024, Science of The Total Environment CrossRef
16. Echinacoside Exerts Antihepatic Fibrosis Effects in High‐Fat Mice Model by Modulating the ACVR2A‐Smad Pathway
    Jie Liang et al, 2024, Molecular Nutrition Food Res CrossRef
17. Polysaccharides from Eucommia ulmoides Oliv. Leaves Alleviate Acute Alcoholic Liver Injury by Modulating the Microbiota–Gut–Liver Axis in Mice
    Yingzhi Li et al, 2024, Foods CrossRef
18. Jian Gan powder ameliorates immunological liver injury in mice by modulating the gut microbiota and metabolic profiles
    Kun Li et al, 2024, Eur J Med Res CrossRef
19. Xiaoer-Feire-Qing granules alleviate pyretic pulmonary syndrome induced by Streptococcus pneumoniae in young rats by affecting the lungs and intestines: an in vivo study based on network pharmacology
    Taotao Wang et al, 2024, Journal of Ethnopharmacology CrossRef
20. Revealing the exceptional antioxidant activity of phosphorylated polysaccharides from medicinal Abrus cantoniensis Hance
    Shuaitao Lian et al, 2024, International Journal of Biological Macromolecules CrossRef
21. Qinggan Yipi capsule ameliorates hepatic fibrosis in rats by down-regulating the TGF-β1/Smad2/3 signaling pathway and improving gut microbiota imbalance
    Wenjing Xue et al, 2025, Front. Pharmacol. CrossRef